Eleonora A. Festen

8.4k citations

70 papers · 2.4k indexed · 1 hit paper · h-index 23

Gastroenterology top 2%
Genetics top 2%
- Inflammatory Bowel Disease 49
Immunology top 5%
- IL-33, ST2, and ILC Pathways 8
Epidemiology top 5%
- Microscopic Colitis 22
- Mycobacterium research and diagnosis 7
Developmental Biology top 10%
Surgery
- Helicobacter pylori-related gastroenterology studies 21
- Eosinophilic Esophagitis 5
Molecular Biology
- Gut microbiota and health 11
- Single-cell and spatial transcriptomics 3

Co-authors: Rinse K. Weersma Cisca Wijmenga Gerard Dijkstra Marijn C. Visschedijk Lude Franke Hendrik M. van Dullemen Jingyuan Fu Arnau Vich Vila
Cited by: Gastroenterology Genetics Immunology
Journals: New England Journal of Medicine (1 paper)Nature Communications (2 papers)Bioinformatics (1 paper)
Partner nations: Netherlands United States Denmark

In The Last Decade

Eleonora A. Festen

67 papers receiving 2.3k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Eleonora A. Festen

Since Specialization

Citations

This map shows the geographic impact of Eleonora A. Festen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleonora A. Festen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleonora A. Festen more than expected).

Fields of papers citing papers by Eleonora A. Festen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleonora A. Festen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleonora A. Festen. The network helps show where Eleonora A. Festen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Eleonora A. Festen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eleonora A. Festen Line = papers co-authored together Eleonora A. Festen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Gut microbiome dysbiosis is not associated with portal vein thrombosis in patients with end-stage liver disease: a cross-sectional study Journal of Thrombosis and Haemostasis ·Rali R Aleksandrova,Lianne M. Nieuwenhuis,Naomi Karmi,Shuyan Zhang,J. Casper Swarte,Johannes R. Björk,Ranko Gaćeša,Hans Blokzijl,Margery A. Connelly,Rinse K. Weersma,Ton Lisman,Eleonora A. Festen,Vincent E. de Meijer,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2025	2
2	P193 Fatigued patients with Inflammatory Bowel Disease exhibit distinct systemic antibody epitope repertoires Journal of Crohn s and Colitis ·M G Griesbaum,Thomas Vogl,Sergio Andreu‐Sánchez,Shelley Klompus,Iris Kalka,Sigal Leviatan,Hendrik M. van Dullemen,Marijn C. Visschedijk,Eleonora A. Festen,Klaas Nico Faber,Gerard Dijkstra,Adina Weinberger,Eran Segal,Rinse K. Weersma,Arno R. Bourgonje	2024	1
3	Fluorescently labelled vedolizumab to visualise drug distribution and mucosal target cells in inflammatory bowel disease Gut ·Ruben Y. Gabriëls,Anne M. van der Waaij,Matthijs D. Linssen,Michael Dobosz,Pia Volkmer,Sumreen Jalal,Dominic J. Robinson,Marcela A. Hermoso,Marjolijn N. Lub–de Hooge,Eleonora A. Festen,Gürsah Kats‐Ugurlu,Gerard Dijkstra,Wouter B. Nagengast	2024	7
4	Mucosal host-microbe interactions associate with clinical phenotypes in inflammatory bowel disease Nature Communications ·Shixian Hu,Arno R. Bourgonje,Ranko Gaćeša,Bernadien H. Jansen,Johannes R. Björk,Amber Bangma,Iwan J. Hidding,Hendrik M. van Dullemen,Marijn C. Visschedijk,Klaas Nico Faber,Gerard Dijkstra,Hermie J. M. Harmsen,Eleonora A. Festen,Arnau Vich Vila,Lieke M. Spekhorst,Rinse K. Weersma	2024	35
5	Exploring the Predictive Value of Gut Microbiome Signatures for Therapy Intensification in Patients With Inflammatory Bowel Disease: A 10-Year Follow-up Study Inflammatory Bowel Diseases ·Zainab M A Al Radi,Femke M. Prins,Valerie Collij,Arnau Vich Vila,Eleonora A. Festen,Gerard Dijkstra,Rinse K. Weersma,Marjolein A. Y. Klaassen,Ranko Gaćeša	2024	8
6	Hepcidin and Iron Status in Patients With Inflammatory Bowel Disease Undergoing Induction Therapy With Vedolizumab or Infliximab Inflammatory Bowel Diseases ·Roberta Loveikyte,Arno R. Bourgonje,Johannes J van der Reijden,Marian Bulthuis,Lukas J.A.C. Hawinkels,Marijn C. Visschedijk,Eleonora A. Festen,Hendrik M. van Dullemen,Rinse K. Weersma,Harry van Goor,Andrea E. van der Meulen‐de Jong,Gerard Dijkstra	2023	11
7	Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease Frontiers in Immunology ·Antonius T. Otten,Arno R. Bourgonje,Petra P. Horinga,Hedwig H. van der Meulen,Eleonora A. Festen,Hendrik M. van Dullemen,Rinse K. Weersma,Coretta van Leer‐Buter,Gerard Dijkstra,Marijn C. Visschedijk	2022	2
8	Serological Biomarkers of Intestinal Collagen Turnover Identify Early Response to Infliximab Therapy in Patients With Crohn’s Disease Frontiers in Medicine ·Marta Sorokina Alexdóttir,Arno R. Bourgonje,M.A. Karsdal,Martin Pehrsson,Roberta Loveikyte,Hendrik M. van Dullemen,Marijn C. Visschedijk,Eleonora A. Festen,Rinse K. Weersma,Klaas Nico Faber,Gerard Dijkstra,Joachim Høg Mortensen	2022	9
9	Donor genetic variants as risk factors for thrombosis after liver transplantation: A genome-wide association study American Journal of Transplantation ·Yanni Li,Lianne M. Nieuwenhuis,Michiel Voskuil,Ranko Gaćeša,Shixian Hu,Bernadien H. Jansen,Werna T. Uniken Venema,Bouke G. Hepkema,Hans Blokzijl,Henkjan J. Verkade,Ton Lisman,Rinse K. Weersma,Robert J. Porte,Eleonora A. Festen,Vincent E. de Meijer	2021	5
10	Cigarette Smoke Increases Risk for Colorectal Neoplasia in Inflammatory Bowel Disease Clinical Gastroenterology and Hepatology ·Kimberley W. J. van der Sloot,Johan Tiems,Marijn C. Visschedijk,Eleonora A. Festen,Hendrik M. van Dullemen,Rinse K. Weersma,Gürsah Kats‐Ugurlu,Gerard Dijkstra	2021	14
11	Environmental factors associated with biological use and surgery in inflammatory bowel disease Journal of Gastroenterology and Hepatology ·Kimberley W. J. van der Sloot,Paul Geertsema,Hanneke C Rijkmans,Michiel Voskuil,Hendrik M. van Dullemen,Marijn C. Visschedijk,Eleonora A. Festen,Rinse K. Weersma,Behrooz Z. Alizadeh,Gerard Dijkstra	2020	4
12	Endoscopic imaging in inflammatory bowel disease: current developments and emerging strategies Expert Review of Gastroenterology & Hepatology ·Jouke J. H. van der Laan,Anne M. van der Waaij,Ruben Y. Gabriëls,Eleonora A. Festen,Gerard Dijkstra,Wouter B. Nagengast	2020	11
13	Genetic Risk Scores Identify Genetic Aetiology of Inflammatory Bowel Disease Phenotypes Journal of Crohn s and Colitis ·Michiel Voskuil,Lieke M. Spekhorst,Kimberley W. J. van der Sloot,Bernadien H. Jansen,Gerard Dijkstra,C. Janneke van der Woude,Frank Hoentjen,Marieke Pierik,Andrea E. van der Meulen‐de Jong,Nanne K.H. de Boer,Mark Löwenberg,Bas Oldenburg,Eleonora A. Festen,Rinse K. Weersma	2020	10
14	The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1 BMC Gastroenterology ·Floris Imhann,K. Joeri van der Velde,Ruggero Barbieri,Rudi Alberts,Michiel Voskuil,Arnau Vich Vila,Valerie Collij,Lieke M. Spekhorst,Kimberley W. J. van der Sloot,Vera Peters,Hendrik M. van Dullemen,Marijn C. Visschedijk,Eleonora A. Festen,Morris A. Swertz,Gerard Dijkstra,Rinse K. Weersma	2019	62
15	SLC39A8 missense variant is associated with Crohn's disease but does not have a major impact on gut microbiome composition in healthy subjects PLoS ONE ·Valerie Collij,Floris Imhann,Arnau Vich Vila,Jingyuan Fu,Gerard Dijkstra,Eleonora A. Festen,Michiel Voskuil,Mark J. Daly,Ramnik J. Xavier,Cisca Wijmenga,Alexandra Zhernakova,Rinse K. Weersma	2019	11
16	Predicting (side) effects for patients with inflammatory bowel disease: The promise of pharmacogenetics World Journal of Gastroenterology ·Michiel Voskuil,Amber Bangma,Rinse K. Weersma,Eleonora A. Festen	2019	36
17	How will insights from genetics translate to clinical practice in inflammatory bowel disease? Best Practice & Research Clinical Gastroenterology ·Eleonora A. Festen,Rinse K. Weersma	2014	12
18	A Meta-Analysis of Genome-Wide Association Scans Identifies IL18RAP, PTPN2, TAGAP, and PUS10 As Shared Risk Loci for Crohn's Disease and Celiac Disease PLoS Genetics ·Eleonora A. Festen,Philippe Goyette,Todd J. Green,Gabrielle Boucher,Claudine Beauchamp,Gosia Trynka,P Dubois,Caroline Lagacé,Pieter Stokkers,Daan W. Hommes,Donatella Barisani,Orazio Palmieri,Vito Annese,David A. van Heel,Rinse K. Weersma,Mark J. Daly,Cisca Wijmenga,John D. Rioux	2011	162
19	Analysis of SNPs with an effect on gene expression identifies UBE2L3 and BCL3 as potential new risk genes for Crohn's disease Human Molecular Genetics ·Karin Fransén,Marijn C. Visschedijk,Suzanne van Sommeren,Jingyuan Fu,Lude Franke,Eleonora A. Festen,Pieter Stokkers,Adriaan A. van Bodegraven,J. Bart A. Crusius,Daniël W. Hommes,Pieter Zanen,Dirk J. de Jong,Cisca Wijmenga,Cleo C. van Diemen,Rinse K. Weersma	2010	77
20	Genetic Analysis in A Dutch Study Sample Identifies More Ulcerative Colitis Susceptibility Loci and Shows Their Additive Role in Disease Risk The American Journal of Gastroenterology ·Eleonora A. Festen,Pieter Stokkers,Cleo C. van Diemen,Adriaan A. van Bodegraven,Marieke H. Boezen,Bart J. A. Crusius,Daniël W. Hommes,C. Janneke van der Woude,Tobias Balschun,Hein W. Verspaget,Stephan J. Schreiber,Dirk J. de Jong,Andre Franke,Gerard Dijkstra,Cisca Wijmenga,Rinse K. Weersma	2009	37

About Eleonora A. Festen

Eleonora A. Festen is a scholar working on Genetics, Epidemiology and Immunology, having authored 70 papers that have together received 2.4k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (49 papers), Microscopic Colitis (22 papers), Helicobacter pylori-related gastroenterology studies (21 papers), Gut microbiota and health (11 papers), IL-33, ST2, and ILC Pathways (8 papers), Mycobacterium research and diagnosis (7 papers), Eosinophilic Esophagitis (5 papers) and Single-cell and spatial transcriptomics (3 papers). The work is most often cited by research in Gastroenterology (219 citations), Genetics (1.1k citations) and Immunology (517 citations). Eleonora A. Festen has collaborated with scholars based in Netherlands, United States and Denmark. Frequent co-authors include Rinse K. Weersma, Cisca Wijmenga, Gerard Dijkstra, Marijn C. Visschedijk, Lude Franke, Hendrik M. van Dullemen, Jingyuan Fu, Arnau Vich Vila, Alexandra Zhernakova and Floris Imhann. Their work appears in journals such as New England Journal of Medicine, Nature Communications and Bioinformatics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact